Method of inducing expression of calcium channel and/or calcium pump, and apparatus therefor

US2022340872A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022340872-A1
Application numberUS-202217729752-A
CountryUS
Kind codeA1
Filing dateApr 26, 2022
Priority dateApr 27, 2021
Publication dateOct 27, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of inducing expression of a calcium channel and/or a calcium pump in a cell includes: irradiating the cell with light in a wavelength range of 315-325 nm. The calcium channel and/or the calcium pump is/are at least one selected from the group consisting of dihydropyridine receptor (DHPR), voltage-gated calcium channel (VGCC), ryanodine receptor (RYR), and sarcoendoplasmic reticulum Ca2+-ATPase (SERCA).

First claim

Opening claim text (preview).

What is claimed is: 1 . A method of inducing expression of a calcium channel and/or a calcium pump in a cell, the method comprising: irradiating the cell with light in a wavelength range of 315-325 nm, wherein the calcium channel and/or the calcium pump is/are at least one selected from the group consisting of dihydropyridine receptor (DHPR), voltage-gated calcium channel (VGCC), ryanodine receptor (RYR), and sarcoendoplasmic reticulum Ca 2+ -ATPase (SERCA). 2 . The method according to claim 1 , wherein in the step of irradiating, the cell is not irradiated with light at any wavelength of 330-400 nm, or is irradiated with light in wavelengths of 330-400 nm at a fluence that is less than 50% of that of the light in the wavelength range of 315-325 nm. 3 . The method according to claim 1 , wherein in the step of irradiating, the cell is not irradiated with light at any wavelength of 200-300 nm, or is irradiated with light in wavelengths of 200-300 nm at a fluence that is less than 30% of that of the light in the wavelength range of 315-325 nm. 4 . The method according to claim 1 , wherein the light in the wavelength range of 315-325 nm has a wavelength spectrum with a peak wavelength at 320±5 nm and a full width at half maximum in a range of 1-20 nm. 5 . The method according to claim 1 , wherein the light in the wavelength range of 315-325 nm is emitted by a light-emitting diode (LED). 6 . The method according to claim 1 , wherein the cell is an excitatory cell. 7 . A method of modulating calcium signaling in a cell, the method comprising: inducing expression of a calcium channel and/or a calcium pump in the cell by applying the method according to claim 1 to the cell; and measuring a physiological event involving calcium signaling in the cell. 8 . The method according to claim 7 , wherein the physiological event is one or more selected from the group consisting of muscle contraction, neuronal transmission, cell death, and osteoblast-like differentiation. 9 . A method of making a cell having induced expression of a calcium channel and/or a calcium pump, comprising: irradiating a cell with light in a wavelength range of 315-325 nm; and freezing the irradiated cell, wherein, in the step of irradiating: the cell is not irradiated with light at any wavelength of 200-300 nm, or is irradiated with light in wavelengths of 200-300 nm at a fluence that is less than 30% of that of the light in the wavelength range of 315-325 nm, and the cell is not irradiated with light at any wavelength of 330-400 nm, or is irradiated with light in wavelengths of 330-400 nm at a fluence that is less than 50% of that of the light in the wavelength range of 315-325 nm. 10 . An apparatus for culturing a cell, the apparatus comprising: a first irradiation unit configured to mainly emit light in a wavelength range of 315-325 nm; a first mounting unit configured to support a cell culture vessel and located within an irradiation area of the first irradiation unit; a first irradiation control unit configured to control the first irradiation unit; and a housing configured to accommodate the first irradiation unit and the first mounting unit therein. 11 . The apparatus according to claim 10 , further comprising: a second irradiation unit configured to mainly emit light in a wavelength range of 315-325 nm and located below the first mounting unit in the housing; a second mounting unit configured to support a cell culture vessel and located within an irradiation area of the second irradiation unit in the housing; a light blocking member and configured to block light in a wavelength range of 315-325 nm, the light blocking member being located in the housing and configured to prevent the light in the wavelength range of 315-325 nm emitted from the first irradiation unit from being irradiated to the second mounting unit; and a second irradiation control unit configured to control the second irradiation unit.

Assignees

Inventors

Classifications

  • C12N5/0062Primary

    General methods for three-dimensional culture · CPC title

  • Electrical or electromagnetic means, e.g. for electroporation or for cell fusion · CPC title

  • located outside the reactor · CPC title

  • Stimulation by light · CPC title

  • of illumination · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022340872A1 cover?
A method of inducing expression of a calcium channel and/or a calcium pump in a cell includes: irradiating the cell with light in a wavelength range of 315-325 nm. The calcium channel and/or the calcium pump is/are at least one selected from the group consisting of dihydropyridine receptor (DHPR), voltage-gated calcium channel (VGCC), ryanodine receptor (RYR), and sarcoendoplasmic reticulum Ca2…
Who is the assignee on this patent?
Nichia Corp
What technology area does this patent fall under?
Primary CPC classification C12N5/0062. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Oct 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).